Release Date: 23/10/13 16:46 Summary: Quarterly Report September 2013 Price Sensitive: Yes Download Document 1.03MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%